ARCT vs AXP · rev $5.0M vs P/E 20, rev $21.73B
Arcturus Therapeutics Holdings Inc (ARCT) versus American Express Company (AXP) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
American Express Company (AXP) is a credit services company listed on US.
Latest reported ARCT revenue for 2026-06-30 was $5.0M. Net income was -$50.7M. ARCT currently screens at market cap $369.4M.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
ARCT currently screens at market cap $369.4M. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Not investment advice. Open the ARCT and AXP stock pages for the full models.
Not investment advice.